Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

X Chen, T Zhang, W Su, Z Dou, D Zhao, X **… - Cell Death & …, 2022 - nature.com
TP53, a crucial tumor suppressor gene, is the most commonly mutated gene in human
cancers. Aside from losing its tumor suppressor function, mutant p53 (mutp53) often …

Cisplatin: mode of cytotoxic action and molecular basis of resistance

ZH Siddik - Oncogene, 2003 - nature.com
Cisplatin is one of the most potent antitumor agents known, displaying clinical activity
against a wide variety of solid tumors. Its cytotoxic mode of action is mediated by its …

Molecular mechanisms of cisplatin resistance

L Galluzzi, L Senovilla, I Vitale, J Michels, I Martins… - Oncogene, 2012 - nature.com
Platinum-based drugs, and in particular cis-diamminedichloroplatinum (II)(best known as
cisplatin), are employed for the treatment of a wide array of solid malignancies, including …

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

M Jain, R Nilsson, S Sharma, N Madhusudhan… - Science, 2012 - science.org
Metabolic reprogramming has been proposed to be a hallmark of cancer, yet a systematic
characterization of the metabolic pathways active in transformed cells is currently lacking …

Molecular mechanisms of drug resistance

DB Longley, PG Johnston - The Journal of Pathology: A Journal …, 2005 - Wiley Online Library
Resistance to chemotherapy limits the effectiveness of anti‐cancer drug treatment. Tumours
may be intrinsically drug‐resistant or develop resistance to chemotherapy during treatment …

The role of p53 in cancer drug resistance and targeted chemotherapy

K Hientz, A Mohr, D Bhakta-Guha, T Efferth - Oncotarget, 2016 - pmc.ncbi.nlm.nih.gov
Cancer has long been a grievous disease complicated by innumerable players aggravating
its cure. Many clinical studies demonstrated the prognostic relevance of the tumor …

Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs

M Hafner, M Niepel, M Chung, PK Sorger - Nature methods, 2016 - nature.com
Drug sensitivity and resistance are conventionally quantified by IC50 or E max values, but
these metrics are highly sensitive to the number of divisions taking place over the course of …

Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer

KJ Chavez, SV Garimella, S Lipkowitz - Breast disease, 2011 - journals.sagepub.com
Breast cancer is the most frequently diagnosed cancer in women and one of the leading
causes of cancer death for women. Worldwide, over 1.3 million cases of invasive breast …

Systems biology of cisplatin resistance: past, present and future

L Galluzzi, I Vitale, J Michels, C Brenner… - Cell death & …, 2014 - nature.com
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …

Cancer cell lines are useful model systems for medical research

P Mirabelli, L Coppola, M Salvatore - Cancers, 2019 - mdpi.com
Cell lines are in vitro model systems that are widely used in different fields of medical
research, especially basic cancer research and drug discovery. Their usefulness is primarily …